1 unchanged sentence
Rule 10b5-1 Trading Arrangements
−Removed: The following table describes contracts, instructions or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) entered into during the quarter ended July 1, 2023.
−Removed: There were no non-Rule 10b5-1 trading arrangements entered into during the quarter ended July 1, 2023.
−Removed: Aggregate Number
−Removed: of Securities to be
−Removed: Purchased or Sold
−Removed: Duration of the
−Removed: Pursuant to the
−Removed: Name and Title of Director or Officer
−Removed: Matthew Johnson
−Removed: President and Chief Executive Officer
−Removed: Expires December 29,
−Removed: Senior Vice President and Chief Financial Officer
−Removed: Expires April 26,
+Added: There were no contracts, instructions or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), nor were there any non-Rule 10b5-1 trading arrangements, entered into or terminated by our directors and officers (as defined under Rule 16b-1(f) of the Exchange Act) during the quarter ended September 30, 2023.
The following exhibits are filed as part of this report:
8 unchanged sentences
Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement).
−Removed: Indenture between Silicon Laboratories Inc.
−Removed: and Wilmington Trust, National Association, as trustee, dated March 6, 2017 (filed as Exhibit 4.1 to the Form 8-K filed on March 6, 2017).
−Removed: Form of 1.375% Convertible Senior Note due 2022 (filed as Exhibit 4.2 to the Form 8-K filed on March 6, 2017).
−Removed: Indenture between Silicon Laboratories Inc.
−Removed: and Wilmington Trust, National Association, as trustee, dated June 1, 2020 (filed as Exhibit 4.1 to the Form 8-K filed on June 1, 2020).
−Removed: Form of 0.625% Convertible Senior Note due 2025 (filed as Exhibit 4.2 to the Form 8-K filed on June 1, 2020).
−Removed: First Supplemental Indenture between Silicon Laboratories Inc.
−Removed: and Wilmington Trust, National Association, as trustee, dated January 2, 2022 (filed as Exhibit 4.1 to the Form 8-K filed on January 3, 2022).
−Removed: Description of Registrant’s Securities Registered under Section 12 of the Exchange Act (filed as Exhibit 4.7 to the Form 10-K filed on February 1, 2023).
Fifth Amendment to Credit Agreement, dated June 30, 2023, by and among Silicon Laboratories Inc., the subsidiaries of the borrower identified therein, Wells Fargo Bank, National Association and the lenders party thereto.
13 unchanged sentences
SILICON LABORATORIES INC.
−Removed: July 26, 2023
+Added: November 1, 2023
Matthew Johnson
3 unchanged sentences
(Principal Executive Officer)
−Removed: July 26, 2023
+Added: November 1, 2023
Senior Vice President and
1 unchanged sentence
(Principal Financial Officer)
−Removed: July 26, 2023
+Added: November 1, 2023
Chief Accounting Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.